[1. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R. O. Quinkert, F. Martin and C. M. Goymann, Phospholipids and lipid-based formulations in oral drug delivery, Pharm. Res. 27 (2010) 1469-1486; DOI: 10.1007/s11095-010-0130-x.10.1007/s11095-010-0130-x]Search in Google Scholar
[2. Y. C. Tseng, Y. Tabata, S. H. Hyon and Y. Ikada, In vitro toxicity test of 2 cyanoacrylate polymers by cell culture method, J. Biomed. Mater. Res. A 24 (1990) 1355-1367; DOI: 10.1002/jbm.820241007.10.1002/jbm.820241007]Search in Google Scholar
[3. K. Lam, J. Schakenraad, H. Esselbrugge, J. Feijen and P. Nieuwenhuis, The effect of phagocytosis of poly(L -lactic acid) fragments on cellular morphology and viability, J. Biomed. Mater. Res. A27 (1993) 1569-1577; DOI: 10.1002/jbm.820271214.10.1002/jbm.820271214]Search in Google Scholar
[4. D. B. Masters and A. J. Domb, Liposphere local anesthetic timed-release for perineural site application, Pharm. Res. 15 (1998) 1038-1045; DOI: 10.1023/A:1011978010724.10.1023/A:1011978010724]Search in Google Scholar
[5. S. Toongsuwan, L. C. Li, B. K. Erickson and H. C. Chang, Formulation and characterization of bupivacaine lipospheres, Int. J. Pharm. 280 (2004) 57-65; DOI: 10.1016/j.bbr.2011.03.031.10.1016/j.bbr.2011.03.031]Search in Google Scholar
[6. A. J. Domb, Long acting injectable oxytetracycline-liposphere formulations, Int. J. Pharm. 124 (1995) 271-278; DOI: 10.1016/0378-5173(95)00098-4.10.1016/0378-5173(95)00098-4]Search in Google Scholar
[7. B. Amarji, D. Raghuwanshi, S. Vyas and P. Kanaujia, Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization, J. Biomed. Nanotechnol.3 (2007) 264-269; DOI: 10.1166/jbn.2007.029.10.1166/jbn.2007.029]Search in Google Scholar
[8. A. Bhatia, B. Singh, V. Rani and O. Katare, Formulation, characterization, and evaluation of benzocaine phospholipid-tagged lipospheres for topical application, J. Biomed. Nanotechnol. 3 (2007) 81-89; DOI: 10.1166/jbn.2007.009.10.1166/jbn.2007.009]Search in Google Scholar
[9. T. Bekerman, J. Golenser and A. Domb, Cyclosporin nanoparticulate lipospheres for oral administration, J. Pharm. Sci. 93 (2004) 1264-1270; DOI: 10.1002/jps.20057.10.1002/jps.2005715067702]Search in Google Scholar
[10. N. Sateeshbabu and K. Gowthamarajan, Manufacturing techniques of lipospheres: overview, Int. J. Pharm. Pharm. Sci. 3 (2011) 17-21.]Search in Google Scholar
[11. United States Pharmacopoeia XXXI, National Formulary XXVI, USP Convention, Rockville (MD) 2008, pp. 2145-2146.]Search in Google Scholar
[12. J. J. Sheng, P. J. Sirois, J. B. Dressman and G. L. Amidon, Particle diffusional layer thickness in a USP dissolution apparatus II: a combined function of particle size and paddle speed, J. Pharm. Sci. 97 (2008) 4815-4829; DOI: 10.1002/jps.21345.10.1002/jps.2134518314890]Search in Google Scholar
[13. T. Higuchi, Mechanisms of sustained action medications: theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149; DOI: 10.1002/jps. 2600521210.]Search in Google Scholar
[14. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83) 90064-9.]Search in Google Scholar
[15. P. Röeschlau, E. Bernt and W. Gruber, Enzymatic determination of total cholesterol in serum, Z. Klin. Chem. Klin. Biochem. 12 (1974) 403-407.]Search in Google Scholar
[16. P. Fossati and L. Prencipe, Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide, Clin. Chem. 28 (1982) 2077-2080.10.1093/clinchem/28.10.2077]Search in Google Scholar
[17. K. D. Kim, D. N. Han and H. T Kim, Optimization of experimental conditions based on the Taguchi robust design for the formation of nano-sized silver particles by chemical reduction method, Chem. Eng. J. 104 (2004) 55-61; DOI: 10.1016/j.cej.2004.08.003.10.1016/j.cej.2004.08.003]Search in Google Scholar
[18. L. Mu and S. S. Feng, Fabrication, characterization and in vitro release of paclitaxel (Taxol®) loaded poly(lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers, J. Control. Release 76 (2001) 239-254; DOI: 10.1016/S0168-3659(01)00440-0.10.1016/S0168-3659(01)00440-0]Search in Google Scholar
[19. A. Dubey, P. Prabhu and J. V. Kamath, Nano structured lipid carriers: A novel topical drug delivery system, Int. J. Pharm. Tech. Res. 4 (2012) 705-714.]Search in Google Scholar
[20. M. Nasr, S. Mansour, N. D. Mortada and A. El. Shamy, Lipospheres as carriers for topical delivery of aceclofenac: Preparation, characterization and in vivo evaluation, AAPS PharmSciTech. 9 (2008) 154-162; DOI: 10.1208/s12249-007-9028-2.10.1208/s12249-007-9028-2297689618446476]Search in Google Scholar
[21. M. Ozyazici, E. H. Gokçe and G. Ertan, Release and diffusional modeling of metronidazole lipidmatrices, Eur. J. Pharm. Biopharm. 63 (2006) 331-339; DOI: 10.1016/j.ejpb.2006.02.005. 10.1016/j.ejpb.2006.02.00516621486]Search in Google Scholar